Skip to content
November 29, 2022

Equity.Guru

Investment information for the new generation

Cleveland BioLabs (CBLI.Q)

Acceleron is finding solutions for serious and rare diseases. It has a pipeline of products moving towards commercialisation, including a co-promotion with the $152 billion Bristol-Myers Squibb (BMY.NYSE)…